Matsuda Masaru 4
4 · Arcutis Biotherapeutics, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2025-12-01$30.23/sh−1,657$50,091→ 150,641 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.
- [F2]Includes 822 shares acquired under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on November 30, 2025.